Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria": Antimicrob Agents Chemother

C. Brunschwig, N. Lawrence, D. Taylor, E. Abay, M. Njoroge, G. S. Basarab, C. Le Manach, T. Paquet, D. Gonzalez Cabrera, A. T. Nchinda, C. de Kock, L. Wiesner, P. Denti, D. Waterson, B. Blasco, D. Leroy, M. J. Witty, C. Donini, J. Duffy, S. WittlinK. L. White, S. A. Charman, M. B. Jimenez-Diaz, I. Angulo-Barturen, E. Herreros, F. J. Gamo, R. Rochford, D. Mancama, T. L. Coetzer, M. E. van der Watt, J. Reader, L. M. Birkholtz, K. C. Marsh, S. M. Solapure, J. E. Burke, J. A. McPhail, M. Vanaerschot, D. A. Fidock, P. V. Fish, P. Siegl, D. A. Smith, G. Wirjanata, R. Noviyanti, R. N. Price, J. Marfurt, K. D. Silue, L. J. Street, K. Chibale

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria": Antimicrob Agents Chemother'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science